Literature DB >> 11106883

The Tromsø study: determinants of precision in bone densitometry.

G K Rosvold Berntsen1, V Fønnebø, A Tollan, A J Søgaard, R M Joakimsen, J H Magnus.   

Abstract

Studies of precision determinants in bone densitometry are scarce. A total of 111 subjects recruited from the population-based multipurpose Tromsø Study (Norway), 27-75 years of age, had repeated forearm bone single X-ray absorptiometry (SXA) measurements. Measurement conditions were systematically varied in series up to eight scans. Median coefficients of variation (CV) for two scans performed 1 week apart, by two different operators were 0.79% and 0.98% at distal and ultradistal sites, respectively. The CV distribution was skewed: 5% of the subjects had individual CVs above 2.2% (distal) and 3.4% (ultradistal). Age (P = 0.0097) and repositioning were important determinants of precision. The SXA bone mineral density (BMD)-measurement method is sufficiently precise to establish BMD level. The minimal individual percentage BMD change that can be detected with 95% certainty was 2% and 3% at distal and ultradistal sites, respectively. Detection of BMD changes less than this should rely on multiple repeat measurements at each point in time.

Entities:  

Mesh:

Year:  2000        PMID: 11106883     DOI: 10.1016/s0895-4356(00)00234-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

1.  Bone mineral density measures in longitudinal studies: the choice of phantom is crucial for quality assessment. The Tromsø study, a population-based study.

Authors:  Nina Emaus; G K R Berntsen; R Joakimsen; V Fønnebø
Journal:  Osteoporos Int       Date:  2005-05-11       Impact factor: 4.507

2.  Leisure time physical activity and risk of non-vertebral fracture in men and women aged 55 years and older: the Tromsø Study.

Authors:  Bente Morseth; Luai A Ahmed; Åshild Bjørnerem; Nina Emaus; Bjarne K Jacobsen; Ragnar Joakimsen; Jan Størmer; Tom Wilsgaard; Lone Jørgensen
Journal:  Eur J Epidemiol       Date:  2012-03-04       Impact factor: 8.082

3.  Height loss, forearm bone density and bone loss in menopausal women: a 15-year prospective study. The Nord-Trøndelag Health Study, Norway.

Authors:  S Forsmo; H M Hvam; M L Rea; S E Lilleeng; B Schei; A Langhammer
Journal:  Osteoporos Int       Date:  2007-03-27       Impact factor: 4.507

4.  Smoking is a strong risk factor for non-vertebral fractures in women with diabetes: the Tromsø Study.

Authors:  L Jørgensen; R Joakimsen; L Ahmed; J Størmer; B K Jacobsen
Journal:  Osteoporos Int       Date:  2010-07-06       Impact factor: 4.507

5.  Anemia and the risk of non-vertebral fractures: the Tromsø Study.

Authors:  L Jørgensen; T Skjelbakken; M-L Løchen; L Ahmed; A Bjørnerem; R Joakimsen; B K Jacobsen
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

6.  Bone loss and the risk of non-vertebral fractures in women and men: the Tromsø study.

Authors:  L A Ahmed; N Emaus; G K Berntsen; A Bjørnerem; V Fønnebø; L Jørgensen; H Schirmer; J Størmer; R M Joakimsen
Journal:  Osteoporos Int       Date:  2009-11-21       Impact factor: 4.507

7.  Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study.

Authors:  L Jørgensen; A Vik; N Emaus; J Brox; J-B Hansen; E Mathiesen; P Vestergaard
Journal:  Osteoporos Int       Date:  2009-08-22       Impact factor: 4.507

8.  Differences in precision in bone mineral density measured by SXA and DXA: the NOREPOS study.

Authors:  Lisa Forsén; Gro K Rosvold Berntsen; Haakon E Meyer; Grethe S Tell; Vinjar Fønnebø
Journal:  Eur J Epidemiol       Date:  2008-07-02       Impact factor: 8.082

9.  Outdoor air pollution, bone density and self-reported forearm fracture: the Oslo Health Study.

Authors:  K Alver; H E Meyer; J A Falch; A J Søgaard
Journal:  Osteoporos Int       Date:  2010-01-14       Impact factor: 4.507

10.  Serum osteoprotegerin levels are related to height loss: the Tromsø Study.

Authors:  Lone Jørgensen; John-Bjarne Hansen; Jan Brox; Ellisiv Mathiesen; Anders Vik; Bjarne K Jacobsen
Journal:  Eur J Epidemiol       Date:  2011-02-18       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.